Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...
justthenews27m
Rep. Nicole Malliotakis calls on Congress to put a stop to FDA-mandated animal testing for cosmetics
Representative Nicole Malliotakis (R-NY) talks about the Humane Cosmetics Act, a bill she cosponsored that would end required ...
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...
Hosted on MSN31m
Federal Judge Revives Legal Effort To Limit Access to Abortion Pill
Efforts to limit access to the abortion drug mifepristone have received a boost from a federal judge who took the bench ...
Hosted on MSN43m
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...